These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 11510267

  • 1. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis?
    Fiedler R, Schneider I, Fischer K, Deuber HJ, Osten B.
    Adv Perit Dial; 2001; 17():159-62. PubMed ID: 11510267
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC, Jeong TK, Lee SC, Kim SW, Kim NH, Lee KY.
    Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
    [Abstract] [Full Text] [Related]

  • 3. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S, Nasini MG, Ravera M, Sanna A, Tirotta A, Lamperi S.
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical significance of peritoneal dialysate IgG levels in CAPD patients.
    De Vecchi A, Castelnovo C, Failla N, Scalamogna A.
    Adv Perit Dial; 1990; 6():98-101. PubMed ID: 1982850
    [Abstract] [Full Text] [Related]

  • 6. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M, Passadakis P, Kriki P, Gioka T, Panagoutsos S, Mourvati E, Thodis E, Kantartzi K, Vargemezis V.
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D, Koomen GC, Hart AA, ten Berge IJ, Struijk DG, Krediet RT.
    J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
    Maksić D, Colić M, Stanković-Popović V, Radojević M, Bokonjić D.
    Med Pregl; 2007 Dec; 60 Suppl 2():53-7. PubMed ID: 18928158
    [Abstract] [Full Text] [Related]

  • 13. Lipopolysaccharide binding protein: a marker for intraperitoneal bacterial infection in patients with CAPD peritonitis.
    Schäfer K, Schumann RR, Stöteknuel S, Böhler J, Schollmeyer P, Dobos GJ.
    Adv Perit Dial; 1997 Dec; 13():210-3. PubMed ID: 9360683
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.